Abstract :

Polycystic Ovary Syndrome (PCOS) is an endocrine disorder that is increasingly affecting women in the reproductive age group. Women commonly experience menstrual irregularities, hirsutism, weight gain, and acne, as well as the development of a complex endocrine disorder that presents with oligomenorrhea, hyperandrogenism, and polycystic ovaries. Herbal medicine is a complex intervention with the potential for synergistic and antagonistic interactions between compounds. These drugs are essential for the treatment of PCOS and have fewer side effects compared to allopathic drugs. One of the herbal medicines to treat PCOS is turmeric or curcumin, curcumin has various biological activities including antioxidant, anti-inflammatory, anti-microbial, anti-tumor, cardioprotective and neuroprotective effects involving various mechanisms. Curcumin can stimulate insulin-mediated glucose uptake via the phosphatidylinositol 3-kinsase (PI3K)/Akt pathway, which, in turn, upregulates glucose transporter 4 (GLUT4) in adipocytes and skeletal muscle, leading to increased glucose levels. Curcumin supplementation improves glycemic control and lipid metabolism, and reduces oxygen radical species in PCOS patients. Curcumin is a diarylheptanoid derived from the rhizome of the Curcuma longa plant, which functions as an anti-inflammatory and antioxidant which is very important in the treatment of PCOS. In addition, nearly half of patients with PCOS develop metabolic syndrome and insulin resistance, and are associated with a much higher risk of type 2 diabetes mellitus.

---

Keywords :

Polycystic Ovarian Syndrome (PCOS), Traditional Medicine, Turmeric

---

References :

1. Jamilian et al., “Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial,” Clin Nutr ESPEN, vol. 36, no. xxxx, pp. 128–133, 2020, doi: 10.1016/j.clnesp.2020.01.005.
2. Y. Jia et al., “The Complementary and Alternative Medicine for Polycystic Ovary Syndrome: A Review of Clinical Application and Mechanism,” Evidence-based Complementary and Alternative Medicine, vol. 2021, 2021, doi: 10.1155/2021/5555315.
3. Shen et al., “Therapeutic effect and safety of curcumin in women with PCOS: A systematic review and meta-analysis,” Front Endocrinol (Lausanne), vol. 13, no. October, pp. 1–16, 2022, doi: 10.3389/fendo.2022.1051111.
4. J. Chien, C. Y. Chang, M. Y. Wu, C. H. Chen, Y. S. Horng, and H. C. Wu, “Effects of curcumin on glycemic control and lipid profile in polycystic ovary syndrome: Systematic review with meta-analysis and trial sequential analysis,” Nutrients, vol. 13, no. 2, pp. 1–14, 2021, doi: 10.3390/nu13020684.
5. Hu et al., “Complementary and Alternative Medicine for the Treatment of Abnormal Endometrial Conditions in Women with PCOS: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,” Evidence-based Complementary and Alternative Medicine, vol. 2021, 2021, doi: 10.1155/2021/5536849.
6. Shetty et al., “Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association,” Cureus, vol. 15, no. 4, pp. 1–9, 2023, doi: 10.7759/cureus.37266.
7. Ee et al., “Feasibility and acceptability of a proposed trial of acupuncture as an adjunct to lifestyle interventions for weight loss in Polycystic Ovary Syndrome: A qualitative study,” BMC Complement Altern Med, vol. 18, no. 1, pp. 1–13, 2018, doi: 10.1186/s12906-018-2358-7.
8. Carmina and R. A. Lobo, “Comparing Lean and Obese PCOS in Different PCOS Phenotypes: Evidence That the Body Weight Is More Important than the Rotterdam Phenotype in Influencing the Metabolic Status,” Diagnostics, vol. 12, no. 10, 2022, doi: 10.3390/diagnostics12102313.
9. Q. Shi et al., “The Application of Complementary and Alternative Medicine in Polycystic Ovary Syndrome Infertility,” Evidence-based Complementary and Alternative Medicine, vol. 2022, 2022, doi: 10.1155/2022/5076306.
10. Balkrishna et al., “Incredible Combination of Lifestyle Modification and Herbal Remedies for Polycystic Ovarian Syndrome Management,” Evidence-Based Complementary and Alternative Medicine, vol. 2023, pp. 1–20, 2023, doi: 10.1155/2023/3705508.
11. Ilmiah Kesehatan Sandi Husada and A. Rika Fahrumnisa, “Turmeric Extract Curcuma longa as Management of Ovarian Polycystic Syndrome,” Jiksh, vol. 10, no. 2, pp. 115–120, 2019, doi: 10.35816/jiskh.v10i2.125.
12. Zhang et al., “Curcumin Inhibits Hyperandrogen-Induced IRE1 α -XBP1 Pathway Activation by Activating the PI3K/AKT Signaling in Ovarian Granulosa Cells of PCOS Model Rats,” Oxid Med Cell Longev, vol. 2022, 2022, doi: 10.1155/2022/2113293.
13. Shen et al., “The Effects of Traditional Chinese Medicine-Associated Complementary and Alternative Medicine on Women with Polycystic Ovary Syndrome,” Evidence-based Complementary and Alternative Medicine, vol. 2021, 2021, doi: 10.1155/2021/6619597.
14. Y. Jia et al., “The Complementary and Alternative Medicine for Polycystic Ovary Syndrome: A Review of Clinical Application and Mechanism,” Evidence-based Complementary and Alternative Medicine, vol. 2021, 2021, doi: 10.1155/2021/5555315.
15. N. Lakshmi et al., “Herbs as a Source for the Treatment of Polycystic Ovarian Syndrome: A Systematic Review,” BioTech, vol. 12, no. 1, 2023, doi: 10.3390/biotech12010004.
16. Zhang et al., “Curcumin in Combination with Aerobic Exercise Improves Follicular Dysfunction via Inhibition of the Hyperandrogen-Induced IRE1 α /XBP1 Endoplasmic Reticulum Stress Pathway in PCOS-Like Rats,” Oxid Med Cell Longev, vol. 2021, 2021, doi: 10.1155/2021/7382900.
17. N. Bari, V. Babapour, A. Ahmadi, M. Z. Kheybari, and G. Akbari, “The effect of curcumin on embryonic in vitro development in experimental polycystic ovary syndrome: An experimental study,” Int J Reprod Biomed, vol. 19, no. 11, pp. 997–1004, 2021, doi: 10.18502/ijrm.v19i11.9915.
18. A. M. Kamal, N. Salamt, A. N. M. Yusuf, M. I. A. M. Kashim, and M. H. Mokhtar, “Potential health benefits of curcumin on female reproductive disorders: A review,” Nutrients, vol. 13, no. 9, 2021, doi: 10.3390/nu13093126.
19. J. Chien, C. Y. Chang, M. Y. Wu, C. H. Chen, Y. S. Horng, and H. C. Wu, “Effects of curcumin on glycemic control and lipid profile in polycystic ovary syndrome: Systematic review with meta-analysis and trial sequential analysis,” Nutrients, vol. 13, no. 2, pp. 1–14, 2021, doi: 10.3390/nu13020684.
20. Heshmati et al., “Effects of curcumin supplementation on blood glucose, insulin resistance and androgens in patients with polycystic ovary syndrome: A randomized double-blind placebo-controlled clinical trial,” Phytomedicine, vol. 80, p. 153395, 2021, doi: 10.1016/j.phymed.2020.153395.
21. Akter et al., “Potentials of curcumin against polycystic ovary syndrome: Pharmacological insights and therapeutic promises,” Heliyon, vol. 9, no. 6, p. e16957, 2023, doi: 10.1016/j.heliyon.2023.e16957.
22. Z. ul H. shah and V. K. Shrivastava, “Turmeric extract alleviates endocrine-metabolic disturbances in letrozole-induced PCOS by increasing adiponectin circulation: A comparison with Metformin,” Metabol Open, vol. 13, p. 100160, 2022, doi: 10.1016/j.metop.2021.100160.
23. Ilmiah Kesehatan Sandi Husada and A. Rika Fahrumnisa, “Turmeric Extract Curcuma longa as Management of Ovarian Polycystic Syndrome,” Jiksh, vol. 10, no. 2, pp. 115–120, 2019, doi: 10.35816/jiskh.v10i2.125.
24. Z. Abuelezz, M. E. Shabana, L. Rashed, and G. N. B. Morcos, “Nanocurcumin modulates mir-223-3p and nf-κb levels in the pancreas of rat model of polycystic ovary syndrome to attenuate autophagy flare, insulin resistance and improve ß cell mass,” J Exp Pharmacol, vol. 13, no. June, pp. 873–888, 2021, doi: 10.2147/JEP.S323962.
25. A. Asan, M. Baş, B. Eren, and E. Karaca, “The effects of curcumin supplementation added to diet on anthropometric and biochemical status in women with polycystic ovary syndrome: A randomized, placebo-controlled trial,” Progress in Nutrition, vol. 22, no. 4, pp. 1–13, 2020, doi: 10.23751/pn.v22i4.10460.
26. Sohaei, R. Amani, M. J. Tarrahi, and H. Ghasemi-Tehrani, “The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial,” Complement Ther Med, vol. 47, no. June, p. 102201, 2019, doi: 10.1016/j.ctim.2019.102201.
27. Z. Abuelezz, M. E. Shabana, H. M. Abdel-Mageed, L. Rashed, and G. N. B. Morcos, “Nanocurcumin alleviates insulin resistance and pancreatic deficits in polycystic ovary syndrome rats: Insights on PI3K/AkT/mTOR and TNF-α modulations,” Life Sci, vol. 256, no. June, p. 118003, 2020, doi: 10.1016/j.lfs.2020.118003.
28. Ghanbarzadeh-Ghashti, S. Ghanbari-Homaie, E. Shaseb, S. Abbasalizadeh, and M. Mirghafourvand, “The effect of Curcumin on metabolic parameters and androgen level in women with polycystic ovary syndrome: a randomized controlled trial,” BMC Endocr Disord, vol. 23, no. 1, pp. 1–11, 2023, doi: 10.1186/s12902-023-01295-5.
29. M. Rababa’h, B. R. Matani, and A. Yehya, “An update of polycystic ovary syndrome: causes and therapeutics options,” Heliyon, vol. 8, no. 10, p. e11010, 2022, doi: 10.1016/j.heliyon.2022.e11010.
30. Jabczyk, J. Nowak, B. Hudzik, and B. Zubelewicz-Szkodzińska, “Curcumin in metabolic health and disease,” Nutrients, vol. 13, no. 12, pp. 1–13, 2021, doi: 10.3390/nu13124440.
31. Zohrabi, M. H. Sheikhha, S. Jambarsang, A. Nadjarzadeh, A. Aflatoonian, and H. Mozaffari-Khosravi, “Effect of dietary approaches to stop hypertension, and standard diets with and without curcumin on interleukin-1 alpha, 5-alpha reductase gene expressions, and androgenic and glycemic profile in polycystic ovary syndrome women undergoing in vitro fertiliz,” Int J Reprod Biomed, vol. 21, no. 5, pp. 433–442, 2023, doi: 10.18502/ijrm.v21i5.13496.
32. Corrie et al., “Combination therapy of curcumin and fecal microbiota transplant: Potential treatment of polycystic ovarian syndrome,” Med Hypotheses, vol. 154, no. July, p. 110644, 2021, doi: 10.1016/j.mehy.2021.110644.
33. Unhapipatpong, N. Polruang, P. C. Shantavasinkul, N. Julanon, P. Numthavaj, and A. Thakkinstian, “The effect of curcumin supplementation on weight loss and anthropometric indices: an umbrella review and updated meta-analyses of randomized controlled trials,” American Journal of Clinical Nutrition, vol. 117, no. 5, pp. 1005–1016, 2023, doi: 10.1016/j.ajcnut.2023.03.006.
34. Therapies et al., “Azadirachta indica : Food Ingredients as Complementary and,” 2022.
35. R. Coelho, M. D. Romi, D. M. T. P. Ferreira, C. Zaltman, and M. Soares-Mota, “The use of curcumin as a complementary therapy in ulcerative colitis: A systematic review of randomized controlled clinical trials,” Nutrients, vol. 12, no. 8, pp. 1–13, 2020, doi: 10.3390/nu12082296.